- Home
- CRVS vs CYH Comparison
CRVS vs CYH Comparison
Compare CRVS & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- CYH
- Stock Information
- Founded
- CRVS 2014
- CYH 1985
- Country
- CRVS United States
- CYH United States
- Employees
- CRVS N/A
- CYH N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- CYH Hospital/Nursing Management
- Sector
- CRVS Health Care
- CYH Health Care
- Exchange
- CRVS Nasdaq
- CYH Nasdaq
- Market Cap
- CRVS 459.0M
- CYH 410.5M
- IPO Year
- CRVS 2016
- CYH 1991
- Fundamental
- Price
- CRVS $7.59
- CYH $4.12
- Analyst Decision
- CRVS Strong Buy
- CYH Hold
- Analyst Count
- CRVS 4
- CYH 8
- Target Price
- CRVS $13.75
- CYH $3.73
- AVG Volume (30 Days)
- CRVS 1.0M
- CYH 2.6M
- Earning Date
- CRVS 11-04-2025
- CYH 10-23-2025
- Dividend Yield
- CRVS N/A
- CYH N/A
- EPS Growth
- CRVS N/A
- CYH N/A
- EPS
- CRVS N/A
- CYH 2.47
- Revenue
- CRVS N/A
- CYH $12,644,000,000.00
- Revenue This Year
- CRVS N/A
- CYH N/A
- Revenue Next Year
- CRVS N/A
- CYH $2.46
- P/E Ratio
- CRVS N/A
- CYH $1.67
- Revenue Growth
- CRVS N/A
- CYH 0.74
- 52 Week Low
- CRVS $2.54
- CYH $2.24
- 52 Week High
- CRVS $10.00
- CYH $4.64
- Technical
- Relative Strength Index (RSI)
- CRVS 58.78
- CYH 72.39
- Support Level
- CRVS $6.81
- CYH $3.01
- Resistance Level
- CRVS $7.96
- CYH $4.43
- Average True Range (ATR)
- CRVS 0.52
- CYH 0.21
- MACD
- CRVS -0.03
- CYH 0.13
- Stochastic Oscillator
- CRVS 67.50
- CYH 80.50
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.